Besponsa (inotuzumab ozogamicin)

pCPA File Number: 21057
Negotiation Status:
Concluded with an LOI
Indication(s):
Acute Lymphoblastic Leukemia
Sponsor/Manufacturer:
Pfizer Canada ULC
CADTH Project Number:
pCODR 10121
pCPA Engagement Letter Issued:
Negotiation Process Concluded: